|
XCAN AG
Luzern, LU, Switzerland
|
|
|
| Main sector |
Medical Technology |
| Subsector |
- Diagnostic and therapeutic radiation devices
- Imaging
|
| Employees |
in Switzerland: 8 |
| Products |
in development: 1
on the market: 1 |
|
Description: XCAN AG develops a direct digital X-ray system for the physician's practice. The services of XCAN AG comprise all areas of the digital physician's practice like diagnostics workstations, patient registration, telecommunications, long time archives, networks etc. To implement the advantages of the future xcan supports the client and attends as a...
|
|
Xeltis AG
Zürich, Switzerland
|
|
|
| Main sector |
Medical Technology |
| Subsector |
- Active implantable devices
- Biomaterials
|
|
Description: Xeltis is engaged in the production of tissue engineered cardiovascular implants such as heart valves, arteries and patches.
|
|
Xenometrix AG
Allschwil, BL, Switzerland
|
|
|
| Main sector |
Biotechnology / R&D Services |
| Subsector |
- Bioinformatics
- CRO (Contract Research Organization)
- Diagnostic instrumentation
- Screening
|
| Employees |
in Switzerland: 7 |
| Products |
on the market: 82 |
|
Description: Xenometrix is a company specialized in the production, distribution and service of mutagenicity test systems, namely Ames II, Ames MPF 98/100, Ames MPF 1535, Ames MPF 1537. The tests come as a complete kit, are quality controlled and are run in a liquid format on 384 well plates.
Xenometrix also produces single and multiple endpoint cytotoxicity...
|
|
XenTech Ltd.
Wabern, BE, Switzerland
|
|
|
| Main sector |
Medical Technology |
| Subsector |
- Other
- Biomaterials
- Non-active implantable devices
|
| Products |
on the market: 3 |
|
Description: XenTech Ltd. Human Device Swiss Company's main production consists of cement and cementless implantations in the fields of orthopaedics and traumatism.
|
|
Xigen SA
Lausanne, VD, Switzerland
|
|
|
| Main sector |
Biotechnology - Therapeutics |
| Subsector |
|
| Indications |
- Diseases of the blood and blood-forming organs; immune disorders
|
| Employees |
in Switzerland: 20 |
| Products |
in development: 5 |
|
Description: Xigen develops intracellular peptide therapeutics for the treatment of inflammatory disorders
|
|
XIRIL AG
Hombrechtikon, ZH, Switzerland
|
|
|
| Main sector |
Supplier & Engineering |
| Subsector |
- Electronics
- Instrumentation
- Laboratory equipment
|
| Employees |
in Switzerland: 25 |
|
Description: The activity of the Company is focused on the development and production of automated systems for life science applications (robotic liquid handling).
|
